(Q24187797)

English

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

scientific article

In more languages

edit

Statements

0 references

0 references

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis (English)

0 references

main subject

Pseudomonas aeruginosa

0 references

0 references

0 references

2

0 references

Helle Krogh Johansen

series ordinal

1

0 references

publication date

23 August 2015

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD001399.PUB4

retrieved

21 January 2018

Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 typeNote

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26298311

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/14651858.CD001399.PUB4

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4715337

OpenCitations bibliographic resource ID

4715337

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4715337

PubMed publication ID

26298311

0 references

(Q24187797)

Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)